Literature DB >> 14494149

Rickettsial and viral antibodies in multiple sclerosis.

C A ROSS.   

Abstract

Entities:  

Keywords:  MULTIPLE SCLEROSIS/etiology; RICKETTSIAL DISEASES/complications; VIRUS DISEASES/complications

Mesh:

Substances:

Year:  1962        PMID: 14494149      PMCID: PMC1958645          DOI: 10.1136/bmj.1.5291.1523

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  Louping-ill the west of Scotland.

Authors:  C A ROSS
Journal:  Lancet       Date:  1961-09-02       Impact factor: 79.321

2.  A plaque technique for the titration of yellow fever virus and antisera.

Authors:  J S PORTERFIELD
Journal:  Trans R Soc Trop Med Hyg       Date:  1959-11       Impact factor: 2.184

3.  [The treatment of sclerosis en plaques of rickettsial or neorickettsial origin].

Authors:  P LE GAC
Journal:  C R Hebd Seances Acad Sci       Date:  1960-03-28

4.  [On a possible rickettsial and neo-rickettsial etiology of multiple sclerosis].

Authors:  P LE GAC; P GIROUD; N DUMAS
Journal:  C R Hebd Seances Acad Sci       Date:  1960-03-07

5.  Historical review of the literature on Q fever.

Authors:  B B WENTWORTH
Journal:  Bacteriol Rev       Date:  1955-09

6.  Virus pneumonia in Glasgow.

Authors:  N R GRIST
Journal:  Lancet       Date:  1954-03-27       Impact factor: 79.321

  6 in total
  4 in total

1.  INFECTIVE AGENTS AND MULTIPLE SCLEROSIS.

Authors:  C A ROSS; J A LENMAN; C RUTTER
Journal:  Br Med J       Date:  1965-01-23

2.  [Measles antibodies in the serum of patients with multiple slcerosis].

Authors:  M Just; H P Rieder; G Ritzel
Journal:  Klin Wochenschr       Date:  1967-07-15

Review 3.  The possible viral aetiology of disseminated sclerosis.

Authors:  F Cathala; P Brown
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

4.  Lack of correlation between impaired interferon production and natural killer activity of lymphocytes in multiple sclerosis.

Authors:  I Stöger; M Tálas; M Benczúr; E Gyódi; G G Petrányi; G Pálffy; B Kotsy
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.